AMS - 2021-UCpd-Urgent Care- Pediatrics

$119.00

5 AMA PRA Category 1 Credits™
$119.00
StreamingINCLUDED

Topics and Objectives

Title: UCpd-Urgent Care- Pediatrics- Skin and Soft Tissue Infections in the Era of Community-Associated Methicillin Resistant Staphylococcus aureus (CA-MRSA): An Evidence-Based Approach; Judicious Use of Antibiotics in Outpatient Setting; Influenza: What’s New and What You Can Do.

Faculty: Rakesh D. Mistry, M.D., M.S. and Robert A. Belfer, M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Skin and Soft Tissue Infections in the Era of Community-Associated Methicillin Resistant Staphylococcus aureus (CA-MRSA): An Evidence-Based Approach.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Detect common skin and soft tissue infections potentially caused by CA-MRSA in children.
  2. Construct a diagnostic approach to common CA-MRSA infections using the most recent pediatric evidence and national guidelines.
  3. Use recent evidence to develop appropriate management strategies for CA-MRSA infections.
  4. Construct an informed approach to antibiotic therapy for skin and soft tissue infections.

TOPIC 2: Judicious Use of Antibiotics in Outpatient Setting.

Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP

  1. Identify antibiotic prescribing patterns, outcomes, and expenditures for common pediatric conditions.
  2. Differentiate between common pediatric infections and those that require antibiotic treatment.
  3. Develop a clinical approach to the diagnosis and therapy of sinusitis.

TOPIC 3: Influenza: What’s New and What You Can Do.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Identify recent changes in influenza epidemiology.
  2. Enumerate CDC recommendations and Guidelines for immunization.
  3. Appropriately prescribe antiviral prophylaxis and treatment.


Total Cost: $

Title: UCpd-Urgent Care- Pediatrics- Skin and Soft Tissue Infections in the Era of Community-Associated Methicillin Resistant Staphylococcus aureus (CA-MRSA): An Evidence-Based Approach; Judicious Use of Antibiotics in Outpatient Setting; Influenza: What’s New and What You Can Do.

Faculty: Rakesh D. Mistry, M.D., M.S. and Robert A. Belfer, M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Skin and Soft Tissue Infections in the Era of Community-Associated Methicillin Resistant Staphylococcus aureus (CA-MRSA): An Evidence-Based Approach.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Detect common skin and soft tissue infections potentially caused by CA-MRSA in children.
  2. Construct a diagnostic approach to common CA-MRSA infections using the most recent pediatric evidence and national guidelines.
  3. Use recent evidence to develop appropriate management strategies for CA-MRSA infections.
  4. Construct an informed approach to antibiotic therapy for skin and soft tissue infections.

TOPIC 2: Judicious Use of Antibiotics in Outpatient Setting.

Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP

  1. Identify antibiotic prescribing patterns, outcomes, and expenditures for common pediatric conditions.
  2. Differentiate between common pediatric infections and those that require antibiotic treatment.
  3. Develop a clinical approach to the diagnosis and therapy of sinusitis.

TOPIC 3: Influenza: What’s New and What You Can Do.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Identify recent changes in influenza epidemiology.
  2. Enumerate CDC recommendations and Guidelines for immunization.
  3. Appropriately prescribe antiviral prophylaxis and treatment.